Healthcare technology leaders Sonio and Samsung Medison have unveiled groundbreaking advancements in artificial intelligence (AI) designed to transform OB-GYN ultrasound workflows. With Sonio introducing its Sonio Voice solution and Samsung Medison debuting its Z20 ultrasound system at the Society for Maternal-Fetal Medicine (SMFM) 2025 conference, both companies aim to address critical challenges in maternal-fetal medicine through innovative tools.
Sonio Voice: Streamlining Ultrasound Reporting
Sonio, an AI-driven MedTech innovator focused on women’s and children’s health, recently announced Sonio Voice—a voice-recognition solution designed to revolutionize OB-GYN ultrasound reporting. According to the company, this tool integrates seamlessly with Sonio’s existing ultrasound reporting platform, using AI to transcribe, analyze, and input ultrasound data in real time. This eliminates manual data entry, enabling sonographers to focus more on patient care.
“With Sonio Voice, we are advancing our mission to lead the AI-driven transformation of ultrasound workflows,” said Cécile Brosset, CEO and co-founder of Sonio. She emphasized the solution’s potential to optimize efficiency and reduce administrative burdens.
Sonio Voice builds upon the company’s cloud-based ultrasound reporting and image management platform, which leverages FDA-cleared clinical AI for quality control and workflow enhancements. The platform is vendor-neutral, compatible with all ultrasound machines, and integrates with electronic health record (EHR) systems and other imaging tools.
Samsung Z20: Enhancing Diagnostic Precision and Ergonomics
Samsung Z20 Ultrasound System
Samsung Medison has introduced the Samsung Z20 at the SMFM 2025 conference in Denver, Colorado. Described as a “premium AI-powered ultrasound system,” the Z20 was designed to tackle some of the most pressing challenges in OB-GYN imaging, including diagnostic accuracy for high-BMI patients and variability among operators.
“The Z20 showcases Samsung’s mission to transform women’s health imaging with breakthrough technology that addresses today’s toughest clinical challenges and delivers the quality care every patient deserves,” said Kyu Tae Yoo, CEO of Samsung Medison.
Key features of the Z20 include:
- Live ViewAssist™: A real-time deep learning tool that streamlines advanced OB exams by automatically identifying 39 views, labeling up to 47 anatomical structures, and performing 46 essential measurements.
- Next-Generation Crystal Architecture™: A new imaging engine that improves diagnostic accuracy through advanced software beamforming.
- Ergonomic Design: To combat work-related musculoskeletal disorders—which affect over 90% of sonographers, according to industry data—the Z20 incorporates features that meet or exceed 100% of ergonomic standards as tested by Sound Ergonomics.
Tracy Bury, Vice President and Head of Ultrasound USA at Samsung Medison, noted, “The Z20 represents a significant technology milestone for both Samsung and the broader ultrasound industry. It reflects our commitment to breaking the iron triangle of healthcare cost, access, and quality.”
Collaboration at SMFM 2025
The SMFM 2025 conference served as a platform for Sonio and Samsung Medison to highlight their partnership, which began in 2024. The companies aim to integrate Sonio’s cloud-based reporting solution with Samsung’s advanced ultrasound systems to streamline maternal-fetal medicine workflows.
At SMFM, Sonio demonstrated its new Sonio Voice alongside Samsung’s Z20 system, showcasing how the combination of their technologies can improve diagnostic accuracy, reduce manual tasks, and enhance clinician well-being.
Implications for Maternal-Fetal Medicine
The launches of Sonio Voice and the Samsung Z20 underscore a growing trend in healthcare: the adoption of AI to address staffing shortages, improve efficiency, and enhance diagnostic precision. These innovations reflect a broader commitment to advancing maternal-fetal medicine through technology.
As the healthcare industry continues to grapple with resource constraints, tools like these are likely to play a critical role in enabling clinicians to deliver higher-quality care more efficiently. By integrating cutting-edge AI with user-centric design, Sonio and Samsung Medison are setting new benchmarks for OB-GYN imaging and maternal-fetal healthcare.
For more information about these solutions, visit Sonio’s website at sonio.ai and Samsung Medison’s Z20 overview at bostonimaging.com.
